GLP-1 Weight-Loss Drugs Spotlight Rare Nutrient Deficiencies
Australian researchers warn that while GLP-1 weight-loss meds are effective, many clinical trials don’t track diet or nutrient intake, potentially increasing long-term malnutrition risk. Rare cases of deficiencies—such as scurvy (vitamin C) and iron or B‑vitamin shortages—have been reported, but are uncommon. The authors urge closer dietary monitoring in clinical practice and future trials, since deficiency symptoms can mimic GLP-1 side effects. The takeaway: nutrition management is essential for sustained success, not a reason to stop treatment.